In a study in which a total of 129 postmortem human brain samples were analyzed in brain regional-specific manner, it found that Ng levels are reduced across the brain regions in all the three dementia groups (DLB, PDD, and AD) compared with the controls (Bereczki et al., 2016). This evidence concerns the gene NRGN and Alzheimer disease.